Nasdaq-listed healthcare provider Basel Medical Group has entered exclusive negotiations to acquire $1 billion worth of Bitcoin—marking one of the largest digital asset moves by a healthcare company to date.
The Singapore-based firm, which specializes in orthopedic and trauma care, announced Friday that the deal would be structured as a share-swap arrangement, allowing Basel to strengthen its treasury without impacting cash reserves. If completed, the acquisition would position Basel as one of the most Bitcoin-heavy healthcare firms in Asia.
Company executives described the plan as a “landmark transaction” aimed at supporting an aggressive expansion strategy into emerging healthcare markets across the region. While no specific investors were named, the company said discussions are ongoing and subject to regulatory approval.
“This $1 billion financial transformation will give us unprecedented capacity to execute our Asia growth strategy while maintaining conservative financial management,” said CEO Dr. Darren Chhoa.
Bitcoin Strategy Goes Mainstream in Corporate Treasury
Basel’s move follows a growing trend among public companies using Bitcoin to reshape their balance sheets. With Bitcoin trading around $104,100—up over 22% in the last month—corporate interest in digital asset strategies is accelerating.
The model was pioneered by Strategy (formerly MicroStrategy), which began acquiring Bitcoin in 2020. As of May 2025, the company holds approximately 569,000 BTC, making it the largest corporate Bitcoin holder. Its bold bet transformed its business model and propelled its stock price from under $15 to around $400 per share, effectively turning MSTR into a Bitcoin proxy for traditional investors.
That success has inspired others across sectors and continents. Japan’s Metaplanet, which now holds 6,796 BTC worth over $700 million, and U.S.-based Semler Scientific are among several mid-cap firms replicating the Strategy playbook—moving reserves out of fiat and into Bitcoin for perceived inflation resistance and long-term value preservation.
Basel’s Bitcoin Bid Signals Healthcare Finance Transformation
Should Basel’s proposed share-swap transaction go through, it would mark the first major crypto treasury move from a healthcare company in Asia and make Basel one of the top institutional holders of Bitcoin in the region.
Analysts note that Basel’s strategy signals a potential shift in healthcare finance, where rising operational costs and competitive pressures are pushing companies to adopt stronger balance sheet tools. By turning to Bitcoin, Basel is not only signaling confidence in crypto’s long-term value, but also positioning itself for cross-sector financial agility.
While healthcare has traditionally lagged behind tech and finance in crypto adoption, Basel’s $1 billion commitment could inspire others in the sector to reevaluate how they manage liquidity and growth capital in the digital age.
Quick Facts
- Basel Medical Group is in exclusive talks to acquire $1 billion in Bitcoin via a share-swap structure.
- The Singapore-based healthcare firm aims to use BTC to fuel expansion across Asia while preserving cash reserves.
- If finalized, the deal would make Basel one of Asia’s top Bitcoin-holding public companies.
- The move mirrors high-profile treasury strategies by firms like Strategy, Metaplanet, and Semler Scientific.
